| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1526-4610.2012.02279.X |
| P698 | PubMed publication ID | 23094760 |
| P50 | author | Domenico D'Amico | Q51846705 |
| Matilde Leonardi | Q56936660 | ||
| Gennaro Bussone | Q78768461 | ||
| Alberto Raggi | Q37830338 | ||
| P2860 | cites work | The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care. | Q45174895 |
| Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study | Q46572337 | ||
| Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial | Q46731911 | ||
| Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study. | Q46761733 | ||
| The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss | Q46800156 | ||
| Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues | Q46875283 | ||
| Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial | Q46910225 | ||
| The Italian SF-36 Health Survey: translation, validation and norming | Q47743666 | ||
| Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial | Q48572094 | ||
| OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine | Q48581359 | ||
| A longitudinal evaluation of changes in disability and quality of life in a sample of women with migraine | Q48679320 | ||
| Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center | Q48779169 | ||
| Work and productivity loss in the rizatriptan multiple attack study. | Q50507084 | ||
| The impact of a migraine attack and its after-effects on perceptual organization, attention, and working memory. | Q50997419 | ||
| Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. | Q51648082 | ||
| A self-administered behavioral intervention using tailored messages for migraine. | Q51839629 | ||
| World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. | Q51872611 | ||
| Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. | Q51903671 | ||
| Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. | Q51948254 | ||
| Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective. | Q53552683 | ||
| Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q28138991 | ||
| The impact of an over-the-counter migraine medication program on quality of life | Q28195052 | ||
| EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force | Q28256451 | ||
| Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan | Q32060372 | ||
| Migraine education improves quality of life in a primary care setting | Q33859925 | ||
| Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases | Q33946584 | ||
| Epidemiology of headache in Europe | Q33995405 | ||
| SF-36 health survey update | Q34109918 | ||
| Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial | Q34167309 | ||
| Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). | Q34200781 | ||
| Developing the World Health Organization Disability Assessment Schedule 2.0 | Q34271065 | ||
| The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache | Q34420699 | ||
| The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 | ||
| Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients | Q34655095 | ||
| The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials | Q36168171 | ||
| Effect of preventive treatment on health-related quality of life in episodic migraine | Q36260569 | ||
| Triptans in the Italian population: a drug utilization study and a literature review | Q36332554 | ||
| Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life | Q36356554 | ||
| Patterns of triptans use: a study based on the records of a community pharmaceutical department | Q36903088 | ||
| The cycle of migraine: patients' quality of life during and between migraine attacks | Q36909877 | ||
| The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research | Q37176674 | ||
| The cost of headache disorders in Europe: the Eurolight project | Q37963926 | ||
| Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes | Q39335482 | ||
| The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache | Q39390568 | ||
| Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial | Q39448293 | ||
| Improvement in migraine-specific quality of life in a clinical trial of rizatriptan | Q39451199 | ||
| Negative impact of episodic migraine on a university population: quality of life, functional impairment, and comorbid psychiatric symptoms | Q39765026 | ||
| Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life | Q39803883 | ||
| Patient preference for triptan formulations: a prospective study with zolmitriptan | Q42632079 | ||
| Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study | Q43551786 | ||
| Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine | Q43795307 | ||
| Health-related quality of life measures and psychiatric comorbidity in patients with migraine | Q43885692 | ||
| Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study. | Q43912873 | ||
| Migraine prevalence, disease burden, and the need for preventive therapy | Q43983035 | ||
| Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks | Q44161144 | ||
| P433 | issue | 2 | |
| P921 | main subject | disability | Q12131 |
| migraine | Q133823 | ||
| quality of life | Q13100823 | ||
| P304 | page(s) | 297-309 | |
| P577 | publication date | 2012-10-24 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | A 3-month analysis of disability, quality of life, and disease course in patients with migraine | |
| P478 | volume | 53 |
| Q30939882 | Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study |
| Q40896923 | Burden of migraine: what should we say more? |
| Q38215466 | Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review |
| Q38108474 | Disability and quality of life in headache: where we are now and where we are heading. |
| Q42025591 | Disability and quality of life in patients with different forms of migraine |
| Q37730599 | Humanistic and economic burden of nausea and vomiting among migraine sufferers |
| Q89685739 | Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study |
| Q55379099 | Physical exercise and migraine: for or against? |
| Q40587371 | Psychosocial difficulties in patients with episodic migraine: a cross-sectional study |
| Q48189333 | Six-month clinical course and factors associated with non-improvement in migraine and non-migraine headaches. |
| Q47366290 | The effect of maternal migraine headache on their children's quality of life |
| Q64083301 | Wet Cupping Reduces Pain and Improves Health-related Quality of Life Among Patients with Migraine: A Prospective Observational Study |
| Q39002028 | World Health Organization disability assessment schedule 2.0: An international systematic review |
Search more.